Clinical Trials Browser

Phase 3 × INDUSTRY × Endocrine × Clear all

Extrapulmonary Neuroendocrine Cancer

Differentiated Thyroid Cancer (DTC)

Carcinoma, Non-Small-Cell Lung, Neoplasms, Multiple Endocrine Neoplasia Type 2a

Advanced Gastroenteropancreatic Neuroendocrine Tumor

Carcinoma, Neuroendocrine

Gastro-enteropancreatic neuroendocrine tumor, Lymphoma, Follicular

Carcinoid Tumors, Intestinal, Carcinoid Tumor, Neuroendocrine Tumors, Serotonin Syndrome

Neuroendocrine Tumors

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

Gastro-enteropancreatic neuroendocrine tumor

Coronary Disease, Multiple Endocrine Neoplasia Type 1

Gastro-enteropancreatic neuroendocrine tumor

Thyroid cancer, follicular, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

Familial medullary thyroid carcinoma, Thyroid Neoplasms, Carcinoma, Medullary

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors

Neuroendocrine Tumors

ACTH Syndrome, Ectopic, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension, Pituitary ACTH Hypersecretion

Advanced Gastroenteropancreatic Neuroendocrine Tumor

Breast Neoplasms, Neoplasms, Multiple Endocrine Neoplasia Type 1

Insulin-Like Growth Factor I, Resistance To, Adrenocortical Carcinoma

Gastro-enteropancreatic neuroendocrine tumor

Differentiated Thyroid Cancer

Differentiated Thyroid Cancer

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Multiple Endocrine Neoplasia Type 1

Differentiated Thyroid Cancer

Neuroendocrine Tumors

Neuroendocrine Tumors

Neuroendocrine Tumors

Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms

Carcinoid Tumor, Diarrhea, Flushing, Neuroendocrine Tumors, Serotonin Syndrome

Neuroendocrine Tumors

Neuroendocrine Tumors in Lung

Neuroendocrine Tumors

Differentiated Thyroid Cancer (DTC)

Differentiated Thyroid Cancer

Neuroendocrine Tumors

Breast Neoplasms, Multiple Endocrine Neoplasia Type 1

Malignant Carcinoid Syndrome, Serotonin Syndrome

Acromegaly, Gigantism, Growth Disorders, Pituitary Neoplasms

Differentiated Thyroid Cancer

Disease, Neuroblastoma, Pheochromocytoma

Bone Diseases, Metabolic, Osteoporosis, Multiple Endocrine Neoplasia Type 1

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

Acromegaly, Pituitary Neoplasms

Advanced Neuroendocrine Tumors of Pancreatic Origin

Thyroid Cancer, Papillary, Adenocarcinoma, Follicular

Carcinoid Tumor, Carcinoma, Malignant Carcinoid Syndrome, Neoplasms

Head and Neck Neoplasms, Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Choristoma, Cushing Syndrome, Hirsutism, Pituitary Diseases, Pituitary ACTH Hypersecretion

ACTH Syndrome, Ectopic, Cushing Syndrome, Pituitary Diseases, Pituitary ACTH Hypersecretion

Clinical Trials

DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer

A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer

An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.

A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma

NETTER-3

CAREFNDR

COMPETE

ACTION-1

NETTER-2

VESALIUS-CV

SORENTO

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer

COMPOSE

A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs

GRACE

Gallium (68Ga) Edotreotide PET/CT for Imaging Patients With Gastrointestinal Pancreatic Neuroendocrine Tumors

SOLAR-1

GALACCTIC

PALACE

VERIFY

Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal

MONALEESA-3

Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer

Phase III Study of Surufatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors

Phase III Study of Surufatinib in Treating Advanced Pancreatic Neuroendocrine Tumors

Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATE

A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver

ELECT

NET729

SPINET

NETTER-1

A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China

DTC

RADIANT-4

A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib

Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome

Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues

ASTRA

Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma

Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis

SEASCAPE

PAOLA

RADIANT-3

A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.

RADIANT-2

FACT2

An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome

Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome